ATE80555T1 - Verfahren zur verhuetung der aids-uebertragung durch blutuebertragung. - Google Patents

Verfahren zur verhuetung der aids-uebertragung durch blutuebertragung.

Info

Publication number
ATE80555T1
ATE80555T1 AT89106943T AT89106943T ATE80555T1 AT E80555 T1 ATE80555 T1 AT E80555T1 AT 89106943 T AT89106943 T AT 89106943T AT 89106943 T AT89106943 T AT 89106943T AT E80555 T1 ATE80555 T1 AT E80555T1
Authority
AT
Austria
Prior art keywords
transmission
blood
methods
preventing aids
aids
Prior art date
Application number
AT89106943T
Other languages
English (en)
Inventor
Peter J Lewis
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE80555T1 publication Critical patent/ATE80555T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyridine Compounds (AREA)
AT89106943T 1988-04-19 1989-04-18 Verfahren zur verhuetung der aids-uebertragung durch blutuebertragung. ATE80555T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888809177A GB8809177D0 (en) 1988-04-19 1988-04-19 Method of preventing aids transmission-resulting from blood transfusions
EP89106943A EP0338515B1 (de) 1988-04-19 1989-04-18 Verfahren zur Verhütung der AIDS-Übertragung durch Blutübertragung

Publications (1)

Publication Number Publication Date
ATE80555T1 true ATE80555T1 (de) 1992-10-15

Family

ID=10635415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89106943T ATE80555T1 (de) 1988-04-19 1989-04-18 Verfahren zur verhuetung der aids-uebertragung durch blutuebertragung.

Country Status (13)

Country Link
US (1) US5039688A (de)
EP (1) EP0338515B1 (de)
JP (1) JPH01311021A (de)
KR (1) KR890015754A (de)
AT (1) ATE80555T1 (de)
AU (1) AU613475B2 (de)
DE (1) DE68902860T2 (de)
DK (1) DK186389A (de)
ES (1) ES2055758T3 (de)
GB (1) GB8809177D0 (de)
GR (1) GR3006218T3 (de)
IE (1) IE891248L (de)
ZA (1) ZA892721B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5419759A (en) * 1988-11-17 1995-05-30 Naficy; Sadeque S. Apparatus and methods for treatment of HIV infections and AIDS
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
DE4302244A1 (de) * 1993-01-27 1994-07-28 Naturwissenschaftliches Und Me Antivirales Chemotherapeutikum mit Breitbandwirkung und dessen Verwendung
ES2078139B1 (es) * 1993-03-05 1996-08-01 Nunez Maria Rosalia Garcia Composiciones antirretrovirales que contienen compuestos iodados.
US5439899A (en) * 1993-03-10 1995-08-08 Purdue Research Foundation Cosalane and related compounds having activity against aids and aids-related infections
JPH10500687A (ja) * 1994-05-20 1998-01-20 ノババックス インコーポレイテッド 抗菌性水中油エマルジョン
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5547677A (en) * 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
DE4444045C2 (de) * 1994-12-10 1997-04-17 Behringwerke Ag Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
JP2006512401A (ja) * 2001-06-05 2006-04-13 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ナノエマルジョンワクチン
DE60219061D1 (de) 2001-11-21 2007-05-03 Altachem Pharma Ltd Antipathogenische zusammensetzung verwendbar in der konservierung von blut
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
CA2545117A1 (en) * 2003-11-07 2005-05-26 Viratox, L.L.C. Virucidal activities of a combination of cetylpyridinium chloride and citric acid
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US20080195023A1 (en) * 2007-02-09 2008-08-14 Daxor Corporation Blood optimization program
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3173208D1 (en) * 1980-10-06 1986-01-23 Edward Shanbrom Method of reducing undesirable activities of biological and pharmaceutical products
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.
DE3781279T2 (de) * 1986-08-01 1993-01-07 Alan I Rubinstein Verfahren zur behandlung von blut.

Also Published As

Publication number Publication date
GR3006218T3 (de) 1993-06-21
AU613475B2 (en) 1991-08-01
EP0338515A1 (de) 1989-10-25
JPH01311021A (ja) 1989-12-15
DE68902860D1 (de) 1992-10-22
EP0338515B1 (de) 1992-09-16
GB8809177D0 (en) 1988-05-25
AU3307589A (en) 1989-10-26
US5039688A (en) 1991-08-13
ES2055758T3 (es) 1994-09-01
DK186389A (da) 1989-10-20
IE891248L (en) 1989-10-19
ZA892721B (en) 1990-03-28
DE68902860T2 (de) 1993-01-21
KR890015754A (ko) 1989-11-25
DK186389D0 (da) 1989-04-18

Similar Documents

Publication Publication Date Title
ATE80555T1 (de) Verfahren zur verhuetung der aids-uebertragung durch blutuebertragung.
FI891483A7 (fi) Lääketieteellinen silmäsuoja
DE69232919D1 (de) Verbindungen und Verfahren zur Inhibierung von HIV- und verwandten Viren
DE69312317D1 (de) Überprüfung von milchvieh
ES271784U (es) Casco protector de la cabeza perfeccionado.
MX163607B (es) Preparaciones de polimeros conteniendo carboxilos
DK180389A (da) Fremgangsmaade til desinfektion af lokaler samt anlaeg til udoevelse af fremgangsmaaden
NO901141D0 (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
DE68917108D1 (de) Methode des Aufbaus eines optoelektronischen Gehäuses und Vorrichtung.
FI913049A7 (fi) Estyneitä kytkentäaineita ja menetelmiä
KR890701640A (ko) 티탄의 테트라키스 유도체로부터 제조된 촉매 및 이를 사용한 올레핀의 중합
DE68928619D1 (de) Verfahren zur Herstellung von mono-N-alkylierten Polyazamacrocyclen
FI925261A7 (fi) Virushepatiitin diagnoosi ja hoito
DE3851925D1 (de) Alkylaminalkoxyphenyl-Derivate, Verfahren zur Verwendung und sie enthaltende Zusammensetzungen.
DE69032738D1 (de) Copolymer von Vinyliden-Cyanid
KR900009588A (ko) 환상 아미드 유도체 및 제초체
FI902821A7 (fi) Infektion leviämisen vähentäminen verenkäsittelylaitteistolla
DE69010172D1 (de) Verfahren zur Vermögenserhöhung von elektroakustischen Tieffrequenzwandlern und damit übereinstimmende Wandler.
DE3673913D1 (de) Ophthalmische gelzubereitung und verfahren zur behandlung von augeninfektionen.
NO892269L (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
DE59205465D1 (de) Vorrichtung zur Tilgung von Torsionsschwingungen
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
DE3752134D1 (de) Verfahren zur Anwendung von den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DE3688307D1 (de) Herbizid und verfahren.
DE3886765D1 (de) Derivate von synergimycinen a und b.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee